Rocket Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.47

+0.03 (+1.23%)

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 11 55%

Hold 7 35%

Sell 2 10%

Price Target

Analyst Price Target +583.0% upside

Low Target $13.87

Average Target $16.87

High Target $23.44

Current Price $2.47

Current
$2.47

Target
$16.87

$13.87 $16.87 avg $23.44

Scenario Analysis

Bear Case

$13.87

461.5%

Low target

Base Case

$16.87

+583.0%

Avg target

Bull Case

$23.44

+849.0%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$5.45

-54.7% from high

52-Week Low

$2.17

+14.1% from low

Target vs 52W High

$16.87

+209.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+115.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-42.4%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.4%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.8%